Operating Profit Margin (OPM) in Pharmaceuticals & Healthcare
How to interpret and apply operating profit margin (opm) when analyzing pharmaceuticals & healthcare stocks in US (NYSE/Nasdaq) markets, with reference to international markets like India.
Quick Recap: What is Operating Profit Margin (OPM)?
Operating margin measures the profit remaining after all operating expenses, revealing how efficiently a company runs its core business operations.
How Operating Profit Margin (OPM) Works Differently in Pharmaceuticals & Healthcare
R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
Typical Ranges for Pharmaceuticals & Healthcare
General benchmark: US sectors: Software 25–40%, Pharma 25–35%, Consumer Staples 15–25%, Industrials 10–18%, Retail 5–10%. Or international markets like India: IT 20–30%, FMCG 15–25%, Banking 30–50%, Manufacturing 10–20%.
Sector data last reviewed: 2026-04
Example Pharmaceuticals & Healthcare Companies to Analyze
Filter pharmaceuticals & healthcare stocks by operating profit margin and other metrics:
Key Takeaways
- Operating Profit Margin (OPM) in pharmaceuticals & healthcare should be compared against sector peers in the same market (US S&P 500 / Russell or Indian NSE / BSE), not the broad market average.
- Sector characteristics: R&D intensive, regulatory risk (USFDA), patent cliffs, mix of domestic and export revenue.
- Cross-list peers across markets, large-cap US names often set the global benchmark, while Indian peers can trade at different multiples due to growth and liquidity differences.
- Always cross-check with other metrics. No single ratio tells the full story.